Zacks Investment Research Lowers Aemetis (AMTX) to Sell

Aemetis (NASDAQ:AMTX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Tuesday.

According to Zacks, “Aemetis, Inc. is an advanced fuels and renewable chemicals company. It produces renewable chemicals and fuels using patented microbes and processes. Aemetis owns and operates an ethanol animal feed plant in California to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. The Company also built, owns, and operates a renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis, Inc. is headquartered in Cupertino, California. “

Separately, B. Riley reaffirmed a “neutral” rating on shares of Aemetis in a report on Wednesday, November 1st.

Shares of Aemetis (AMTX) traded down $0.03 during midday trading on Tuesday, reaching $0.54. The company’s stock had a trading volume of 25,800 shares, compared to its average volume of 35,811. The stock has a market cap of $10.41, a P/E ratio of -0.45 and a beta of 1.78. The company has a debt-to-equity ratio of -1.87, a current ratio of 0.37 and a quick ratio of 0.20. Aemetis has a 12 month low of $0.45 and a 12 month high of $1.81.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Ninepoint Partners LP purchased a new stake in shares of Aemetis in the 3rd quarter valued at about $1,002,000. Geneva Advisors LLC lifted its holdings in shares of Aemetis by 4.9% in the 3rd quarter. Geneva Advisors LLC now owns 1,453,131 shares of the specialty chemicals company’s stock valued at $1,569,000 after purchasing an additional 68,460 shares during the last quarter. Finally, Atlantic Trust Group LLC purchased a new stake in shares of Aemetis in the 3rd quarter valued at about $1,278,000. 17.73% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/02/13/zacks-investment-research-lowers-aemetis-amtx-to-sell.html.

Aemetis Company Profile

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Get a free copy of the Zacks research report on Aemetis (AMTX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply